Cargando…
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968–2000
The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic con...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541201/ https://www.ncbi.nlm.nih.gov/pubmed/28511068 http://dx.doi.org/10.1016/j.shpsc.2017.05.004 |